🚀 VC round data is live in beta, check it out!
IVF hartmann Valuation Multiples
Discover revenue and EBITDA valuation multiples for IVF hartmann and similar public comparables like AngioDynamics, Myriad Genetics, Beta Bionics, Imricor Medical Systems and more.
IVF hartmann Overview
About IVF hartmann
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
Founded
1874
HQ
Employees
316
Website
Sectors
Financials (FY)
EV
$282M
IVF hartmann Financials
IVF hartmann reported last fiscal year revenue of $204M and EBITDA of $33M.
In the same fiscal year, IVF hartmann generated $113M in gross profit, $33M in EBITDA, and $23M in net income.
IVF hartmann P&L
In the most recent fiscal year, IVF hartmann reported revenue of $204M and EBITDA of $33M.
IVF hartmann expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $204M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $113M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 56% | XXX | XXX | XXX |
| EBITDA | — | XXX | $33M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 13% | XXX | XXX | XXX |
| Net Profit | — | XXX | $23M | XXX | XXX | XXX |
| Net Margin | — | XXX | 11% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
IVF hartmann Stock Performance
IVF hartmann has current market cap of $421M, and enterprise value of $282M.
Market Cap Evolution
IVF hartmann's stock price is $176.90.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $282M | $421M | 0.6% | XXX | XXX | XXX | $9.71 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialIVF hartmann Valuation Multiples
IVF hartmann trades at 1.4x EV/Revenue multiple, and 8.5x EV/EBITDA.
IVF hartmann Financial Valuation Multiples
As of April 11, 2026, IVF hartmann has market cap of $421M and EV of $282M.
Equity research analysts estimate IVF hartmann's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
IVF hartmann has a P/E ratio of 18.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $421M | XXX | $421M | XXX | XXX | XXX |
| EV (current) | $282M | XXX | $282M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 8.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 10.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.5x | XXX | XXX | XXX |
| P/E | — | XXX | 18.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 12.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified IVF hartmann Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
IVF hartmann Margins & Growth Rates
IVF hartmann's revenue in the last fiscal year grew by 2%.
IVF hartmann's revenue per employee in the last FY averaged $0.6M, while opex per employee averaged $0.3M for the same period.
IVF hartmann Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 16% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (11%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.6M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 43% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
IVF hartmann Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AngioDynamics | XXX | XXX | XXX | XXX | XXX | XXX |
| Myriad Genetics | XXX | XXX | XXX | XXX | XXX | XXX |
| Beta Bionics | XXX | XXX | XXX | XXX | XXX | XXX |
| Imricor Medical Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Medmix | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
IVF hartmann M&A Activity
IVF hartmann acquired XXX companies to date.
Last acquisition by IVF hartmann was on XXXXXXXX, XXXXX. IVF hartmann acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by IVF hartmann
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialIVF hartmann Investment Activity
IVF hartmann invested in XXX companies to date.
IVF hartmann made its latest investment on XXXXXXXX, XXXXX. IVF hartmann invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by IVF hartmann
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout IVF hartmann
| When was IVF hartmann founded? | IVF hartmann was founded in 1874. |
| Where is IVF hartmann headquartered? | IVF hartmann is headquartered in Switzerland. |
| How many employees does IVF hartmann have? | As of today, IVF hartmann has over 316 employees. |
| Is IVF hartmann publicly listed? | Yes, IVF hartmann is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of IVF hartmann? | IVF hartmann trades under VBSN ticker. |
| When did IVF hartmann go public? | IVF hartmann went public in 2012. |
| Who are competitors of IVF hartmann? | IVF hartmann main competitors are AngioDynamics, Myriad Genetics, Beta Bionics, Imricor Medical Systems. |
| What is the current market cap of IVF hartmann? | IVF hartmann's current market cap is $421M. |
| What is the current revenue of IVF hartmann? | IVF hartmann's last fiscal year revenue is $204M. |
| What is the current EV/Revenue multiple of IVF hartmann? | Current revenue multiple of IVF hartmann is 1.4x. |
| Is IVF hartmann profitable? | No, IVF hartmann is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.